A Cochrane review pooled nine trials of regulated medical cannabis for insomnia, covering 537 adults aged 18 to 76, and found ...

Bayer has secured US FDA marketing approval for Sunharbo (asundexian), tablets, marking a major milestone in stroke ...

Certain handwriting features, such as writing efficiency and coordination, may shed light on the cognitive health of older ...

Zero HIV Acquisitions Occurred Among Participants Receiving Twice-Yearly Lenacapavir During the 52-Week Study Period PURPOSE 5 Study Findings Highlight the Potential of Long-Acting HIV Prevention ...

Patients on Vafseo® (vadadustat) increased to approximately 11,500 at the end of Q3 2026 representing an increase of approximately 140% from the ...

These are the gifts we've tried, tested, and loved this year — and the gifts on our own personal wishlists.

A qualitative study published in Discover Health Systems examines the lived experiences of community members interacting with ...

Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced topline results from VOCAL, an ...

Preferred Source Google Discover NewsVoir  New Delhi [India], November 9: Morepen Laboratories Limited announced the launch ...

A major new review challenges the growing enthusiasm for medical cannabis as an insomnia treatment, finding little reliable ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, ...